2004
Transaction will bring together cardiovascular expertise and technologies to benefit patients and physicians worldwide New Brunswick, N.J. and Indianapolis, Ind. - Johnson & Johnson (NYSE: JNJ),...
Company Reiterates Guidance for the Fourth Quarter 2004, Full-Year 2004 and 2005 Indianapolis, Ind. - Guidant Corporation (NYSE: GDT) today provided a mid-quarter update reiterating financial...
Presentation Accessible Via Webcast Indianapolis, Ind. - Guidant Corporation (NYSE: GDT), a world leader in the treatment of cardiac and vascular disease, today announced that it will participate...
Presentation Accessible Via Webcast Indianapolis, Ind. - Guidant Corporation (NYSE: GDT), a world leader in the treatment of cardiac and vascular disease, today announced that it will participate...
CAPTURE Will Advance Understanding of Carotid Stenting In High-Risk Patients at 150 U.S. Sites Indianapolis, Ind. - Guidant Corporation (NYSE: GDT) today announced that the company has begun...
Proposed Expanded Medicare Coverage for Implantable Defibrillators, SPIRIT FIRST Drug Eluting Stent Results and Carotid Stent System Approval Highlight Quarter Worldwide implantable defibrillator...
Indianapolis, Ind. - Guidant Corporation (NYSE: GDT) today announced that the company''s board of directors declared a fourth quarter dividend of $0.10 per share on outstanding common stock. This...
INDIANAPOLIS, IND. - Guidant Corporation (NYSE: GDT) will conduct a live webcast of its third quarter 2004 earnings conference call on Thursday, October 21, at 11:00 a.m. EDT. Guidant will issue a...
Endoscopic Vessel Harvesting Reduces Pain, Minimizes Scarring and Speeds Recovery Indianapolis, Ind. and Santa Clara, Calif. - Guidant Corporation (NYSE: GDT) today announced U.S. Food and Drug...
Guidant-Supported Grant Honors Late Chief Medical Officer Indianapolis, Ind. - Guidant Corporation (NYSE: GDT) today announced that Farouc A. Jaffer, M.D., of Massachusetts General Hospital,...
Results Demonstrate the Benefit of An Everolimus Eluting Coronary Stent with Durable Polymer; Investor Briefing Scheduled for 8:00 a.m. ET Tomorrow Indianapolis, Ind., and Washington, D.C. -...
Lifesaving Benefits of Implantable Defibrillators Supported by Multiple Clinical Trials Indianapolis, Ind. and St. Paul, Minn. - Guidant Corporation (NYSE: GDT) today applauds the proposed...
Goal of Study Is To Help Physicians Recognize Patients At Risk of Unexpected Heart Attack Indianapolis, Ind. and Washington, D.C. - Guidant Corporation (NYSE: GDT) today announced plans to conduct...
Highly Deliverable New Stent Broadens Guidant''s Market-Leading Metallic Stent Portfolio Indianapolis, Ind. and Santa Clara, Calif. - Guidant Corporation (NYSE: GDT) today announced U.S. Food and...
International Trial Will Study Unnecessary Pacing in Heart Failure Patients Indianapolis, Ind. And St. Paul, Minn. - Guidant Corporation (NYSE: GDT) today announced that it has completed...
Indianapolis, Ind. and St. Paul, Minn. - Guidant Corporation (NYSE: GDT) today announced that the U.S. Food and Drug Administration (FDA) has approved an expanded indication for the company''s...
National Registry Will Now Focus on Patient Identification and Treatment Indianapolis, Ind. and St. Paul, Minn. - Guidant Corporation (NYSE:GDT) today announced that its ADVANCENTSM national...
Presentation Accessible Via Webcast Indianapolis, Ind. - Guidant Corporation (NYSE: GDT), a world leader in the treatment of cardiac and vascular disease, today announced that it will participate...
Indianapolis, Ind. and Santa Clara, Calif. - Guidant Corporation (NYSE: GDT) today commended the Centers for Medicare & Medicaid Services (CMS) for its intent to expand coverage of carotid artery...
Federal Circuit Court of Appeals Returns the Case to Lower Court to Determine Infringement and Damages Indianapolis, Ind. - Guidant Corporation (NYSE: GDT) today announced that it won its appeal...
New Carotid Stent System Offers Minimally Invasive Alternative to Open Surgery Indianapolis, Ind. and Santa Clara, Calif. - Guidant Corporation (NYSE: GDT) today announced U.S. Food and Drug...
Collaboration Explores Advanced Applications for Gene Therapy to Benefit Heart Patients Indianapolis, Ind. and St. Paul, Minn. - Guidant Corporation (NYSE: GDT) today announced a collaboration...
Company to Reiterate Third Quarter and Full-Year Guidance Indianapolis, Ind. - Guidant Corporation (NYSE: GDT) will host its previously announced mid-quarter conference call today, Thursday, , at...
Live Webcast Available Indianapolis, Ind. - Guidant Corporation (NYSE: GDT) today announced that it will host its regularly scheduled mid-quarter conference call to provide an update on the...
Indianapolis, Ind. - Guidant Corporation (NYSE: GDT) today announced that the company''s board of directors declared a third quarter dividend of $0.10 per share on outstanding common stock. This...
Advanced Leads and Lead Delivery System Further Strengthen Company''s Heart Failure Portfolio Indianapolis, IN and St. Paul, MN - Guidant Corporation (NYSE: GDT) today announced U.S. Food and Drug...
U.S. Food and Drug Administration Advisory Committee Approval Based on Data from Company''s Landmark COMPANION Heart Failure Trial Indianapolis, Ind. and St. Paul, Minn. - Guidant Corporation...
New Rapid-Exchange Dilatation Catheter Provides Foundation for Successful Interventional Procedures Indianapolis, Ind. and Santa Clara, Calif. - Guidant Corporation (NYSE: GDT) today announced the...
Sales led by strong growth in worldwide implantable defibrillators Worldwide implantable defibrillator revenue of $456 million, up 21 percent Worldwide pacemaker revenue of $183 million, up 7 percent
Innovative System Combines Treatments for Heart Failure, Atrial Arrhythmias and Sudden Cardiac Death Indianapolis, Ind. and St. Paul, Minn. - Guidant Corporation (NYSE: GDT) today announced...
INDIANAPOLIS-Guidant Corporation (NYSE: GDT) will conduct a live webcast of its second quarter 2004 earnings conference call on Thursday, July 22 at 11:00 a.m. EDT. The company will issue a press...
Company Makes Staged Equity Investment in Miravant Medical Technologies Indianapolis, Ind. and Santa Clara, Calif. - Guidant Corporation (NYSE: GDT) today announced an agreement with Miravant...
Indianapolis, Ind. - Guidant Corporation (NYSE: GDT) will host its previously announced conference call today, , at 4:30 PM EDT. On the call, the company will provide an update on its lead drug...
Webcast Scheduled for July 1 at 4:30 PM EDT Indianapolis, Ind. - Guidant Corporation (NYSE: GDT) today announced that it will host its previously announced conference call on Thursday, July 1,...
Guidant Seeks to Expand User Labeling, Including Indications, for Cardiac Resynchronization Therapy Defibrillators Indianapolis, Ind. and St. Paul, Minn. - Guidant Corporation (NYSE: GDT) today...
Indianapolis, Ind. - Guidant Corporation (NYSE: GDT) today announced that it will participate in the Goldman Sachs 25th Annual Global Healthcare Conference on Tuesday, June 8, in Laguna Nigel, Calif.
Guidant Customers in Europe to Obtain Access to Pioneering Technology Indianapolis, Ind. and Santa Clara, Calif. - Guidant Corporation (NYSE: GDT) today announced that the company has begun...
Indianapolis, Ind. - Guidant Corporation (NYSE: GDT) today reaffirmed on the company''s mid-quarter conference call its previously stated guidance for the second quarter - sales in the range of...
MULTI-LINK MINI VISION Coronary Stent System and VOYAGER Coronary Dilatation Catheter Enable Physicians to More Easily Treat Patients with Complex Coronary Artery Disease Indianapolis, Ind. and...
Mid-Quarter Conference Call Tomorrow at 9:00 AM EDT Indianapolis, Ind. - Guidant Corporation (NYSE: GDT) will host its previously announced mid-quarter conference call tomorrow, May 27, 2004, at...
SPIRIT FIRST 30-Day and FUTURE II One-Year Results Continue to Support Benefit of Everolimus Eluting Coronary Stents Indianapolis, Ind., and Paris - Guidant Corporation (NYSE: GDT) today announced...
Evalve, Inc.''s Innovative Technology Designed to Offer New Treatment Option for Debilitating Condition Indianapolis, Ind. and Santa Clara, Calif. - Guidant Corporation (NYSE: GDT) today announced...
Trial Results Support Therapy for Extending and Improving the Lives of People with Advanced Heart Failure Indianapolis, Ind. and St. Paul, Minn. - Guidant Corporation (NYSE: GDT) today announced...
Dollens will Remain President and CEO Until His Retirement; Guido J. Neels Elevated to Chief Operating Officer Indianapolis, Ind. - Guidant Corporation (NYSE: GDT) will announce today at its...
Indianapolis, Ind. - Guidant Corporation (NYSE: GDT) today announced that the company''s board of directors declared a second quarter dividend of $0.10 per share on outstanding common stock. This...
Live Webcast Available Indianapolis, Ind. - Guidant Corporation (NYSE: GDT) today announced that it will host a mid-quarter conference call to provide an update on the company''s business. The...
Live Webcast Available Indianapolis, Ind. - Guidant Corporation (NYSE: GDT), today announced that it will participate in the Deutsche Bank Securities 29th Annual Healthcare Conference on...
Live Webcast Available Indianapolis, Ind. - Guidant Corporation (NYSE: GDT), today announced that it will participate in the Morgan Stanley Global Healthcare Unplugged Conference on Thursday, May...
Worldwide implantable defibrillator revenue of $405 million, up 22 percent. Worldwide stent revenue of $171 million, down 22 percent. Progress on drug-eluting stent programs through achievement of...
Stent Successfully Treats Patients with Difficult Coronary Blockages Indianapolis, Ind. and Santa Clara, Calif. - Guidant Corporation (NYSE: GDT) today announced Conformité Européenne (CE) Mark...
Innovative Technology Could Represent New Frontier in Treatment of Heart Disease Indianapolis, Ind. and Santa Clara, Calif. - Guidant Corporation (NYSE: GDT) today announced the $6 million...
Indianapolis - As previously announced, Guidant Corporation (NYSE: GDT) will conduct a live webcast of its first quarter 2004 earnings conference call on Thursday, April 22 at 11:00 a.m. EDT. The...
World''s Smallest, Thinnest Defibrillator Offers Advanced Rhythm Discrimination and Industry-Leading Longevity Indianapolis, IN and St. Paul, MN - Guidant Corporation (NYSE: GDT), a world leader...
Indianapolis, Ind. - Guidant Corporation (NYSE: GDT) today announced that Bernard E. Kury will join Guidant as vice president and general counsel, effective April 12. Kury will report to Ronald W....
Reflects Strength Across Major Product Lines; Company Announces Live Webcast of its First Quarter Earnings Conference Call Indianapolis, Ind. - Guidant Corporation (NYSE: GDT) today announced...
Everolimus Eluting Stent Trial Will Provide Additional Safety and Performance Data Indianapolis, Ind. and Santa Clara, Calif. - Guidant Corporation (NYSE: GDT) today announced that the first...
Important Milestone Achieved in Guidant''s Everolimus Eluting Stent Program; Next-Generation Drug Eluting Stent Utilizes Company''s VISION Cobalt Chromium Stent Technology Indianapolis, Ind., and...
Results Will Broaden Patient Population Who Clearly Benefit from an Implantable Defibrillator Indianapolis, Ind. and St. Paul, Minn. - Guidant Corporation (NYSE: GDT), a world leader in the...
Results Presented Today at American College of Cardiology Conference in New Orleans Indianapolis, Ind., and Santa Clara, Calif. - Guidant Corporation (NYSE: GDT), a world leader in the treatment...
Company Will Announce Final Results of Studies Evaluating New Stroke Prevention Technology at Late-Breaking Clinical Trials Session Indianapolis, Ind. - Guidant Corporation (NYSE: GDT), a world...
INDIANAPOLIS - Guidant Corporation (NYSE: GDT), a world leader in the treatment of cardiac and vascular disease, announced today that its board of directors has elected Jack A. Shaw, retired...
Agreement with Cordis, a Johnson & Johnson Company, Strengthens Guidant''s Broad Product Portfolio; Live Webcast Available Today at 9:00 AM EST Indianapolis, Ind. - Guidant Corporation (NYSE:...
Indianapolis, Ind. - Guidant Corporation (NYSE: GDT), a world leader in the treatment of cardiac and vascular disease, today announced that it has entered into an agreement with Boston Scientific...
Company Announces Share Repurchase Program INDIANAPOLIS - Guidant Corporation (NYSE: GDT), a world leader in the treatment of cardiac and vascular disease, today announced that the company''s...
Fourth quarter highlights: Worldwide implantable defibrillator revenue of $396 million, up 30 percent Worldwide stent revenue of $202 million, down 17 percent; up 2 percent versus third quarter...
Guidant Receives FDA Approval Based on COMPANION Clinical Trial Data Indianapolis, Ind. and St. Paul, Minn. - Guidant Corporation (NYSE: GDT), a world leader in the treatment of cardiac and...
Presentation Accessible Via Webcast Indianapolis, Ind. - Guidant Corporation (NYSE: GDT), a world leader in the treatment of cardiac and vascular disease, today announced that it will participate...
Acquisition Positions Guidant to Enter New Therapy Area Indianapolis, Ind. and Santa Clara, Calif. - Guidant Corporation (NYSE: GDT), a world leader in the treatment of cardiac and vascular...
Indianapolis, Ind. - Guidant Corporation (NYSE: GDT), a world leader in the treatment of cardiac and vascular disease, will conduct a live webcast of its fourth quarter 2003 earnings conference...
Self-Expanding Stent Features New, More Accurate Delivery System Indianapolis, Ind. - Guidant Corporation (NYSE: GDT), a world leader in the treatment of cardiac and vascular disease, today...
Dean of Duke University''s Pratt School of Engineering Will Stand for Re-Election by Guidant Shareholders in May Indianapolis, Ind. - Guidant Corporation (NYSE: GDT), a world leader in the...
Live Webcast Available INDIANAPOLIS - Guidant Corporation (NYSE: GDT), a world leader in the treatment of cardiac and vascular disease, today announced that it will participate in the JPMorgan...